Experiments on mice reveal the parts of the brain involved in motion sickness

by Bob Yirka , Medical XpressIdentification of glutamatergic neuronal subpopulations in the VN. (A)Slc17a6Cremice were bilaterally injected in the VN with a viral vector expressing the Rib

Updated on: January 11,2024

Experiments on mice reveal the parts of the brain involved in motion sickness

by Bob Yirka , Medical XpressIdentification of glutamatergic neuronal subpopulations in the VN. (A)Slc17a6Cremice were bilaterally injected in the VN with a viral vector expressing the Rib

Updated on:January 11,2024

Discoveries on memory mechanisms could unlock new therapies for Alzheimer's and other brain diseases

by CU Anschutz Medical CampusCredit: Pixabay/Pete Linforth.Scientists at the University of Colorado Anschutz Medical Campus have made a 'paradigm shifting' discovery on the mechanisms req

Updated on: June 18,2024

Discoveries on memory mechanisms could unlock new therapies for Alzheimer's and other brain diseases

by CU Anschutz Medical CampusCredit: Pixabay/Pete Linforth.Scientists at the University of Colorado Anschutz Medical Campus have made a 'paradigm shifting' discovery on the mechanisms req

Updated on:June 18,2024

How do we get more women into health care and medical leadership?

by Medical Journal of Australia (MJA)Credit: National Cancer Institute on UnsplashWomen continue to be under-represented in health care and medical leadership in Australia, with experts labeling the d

Updated on: March 19,2024

How do we get more women into health care and medical leadership?

by Medical Journal of Australia (MJA)Credit: National Cancer Institute on UnsplashWomen continue to be under-represented in health care and medical leadership in Australia, with experts labeling the d

Updated on:March 19,2024

Gene-editing tools pave way for new Alzheimer's treatments

by Cara MurezTwo new studies using CRISPR gene editing offer potential new treatments for Alzheimer's disease."A pipeline of potential new treatments offers hope for the Alzheimer's and d

Updated on: June 14,2024

Gene-editing tools pave way for new Alzheimer's treatments

by Cara MurezTwo new studies using CRISPR gene editing offer potential new treatments for Alzheimer's disease."A pipeline of potential new treatments offers hope for the Alzheimer's and d

Updated on:June 14,2024

Early-life exposure to manganese may be beneficial to adolescent cognition

by Jillian McKoy,Boston UniversityAdjusted beta (β) estimates and 95% CIs from multivariable linear regression models assessing associations between prenatal, postnatal, and childhood tooth Mn l

Updated on: January 10,2024

Early-life exposure to manganese may be beneficial to adolescent cognition

by Jillian McKoy,Boston UniversityAdjusted beta (β) estimates and 95% CIs from multivariable linear regression models assessing associations between prenatal, postnatal, and childhood tooth Mn l

Updated on:January 10,2024

Tauvid receives approval for tau pathology imaging

(HealthDay)—Tauvid (flortaucipir F18), a radioactive diagnostic agent, was approved to image tau pathology in patients with cognitive impairment being evaluated for Alzheimer disease, the U.S. Food an

Updated on: April 02,2024

Tauvid receives approval for tau pathology imaging

(HealthDay)—Tauvid (flortaucipir F18), a radioactive diagnostic agent, was approved to image tau pathology in patients with cognitive impairment being evaluated for Alzheimer disease, the U.S. Food an

Updated on:April 02,2024

Prospects continue to improve for people with MS, but disease management in older adults presents challenges

by Ellen Goldbaum,University at BuffaloCredit: Anna Shvets from PexelsThe past five years have seen significant advancements in diagnosing and treating multiple sclerosis (MS), but challenges re

Updated on: January 10,2024

Prospects continue to improve for people with MS, but disease management in older adults presents challenges

by Ellen Goldbaum,University at BuffaloCredit: Anna Shvets from PexelsThe past five years have seen significant advancements in diagnosing and treating multiple sclerosis (MS), but challenges re

Updated on:January 10,2024

Dementia test to expand diagnosis across India

by University of East AngliaCredit: CC0 Public DomainA standardised test that can now be used in the seven main languages in India will support the diagnosis of dementia and mild cognitive impair

Updated on: May 06,2024

Dementia test to expand diagnosis across India

by University of East AngliaCredit: CC0 Public DomainA standardised test that can now be used in the seven main languages in India will support the diagnosis of dementia and mild cognitive impair

Updated on:May 06,2024

Stretchable probe measures brain chemicals central to Parkinson's, depression, and gut disease

by Stanford UniversityResearchers demonstrated the advantages of the flexible and elastic NeuroString technology by threading a probe through a segment of mouse colon. Credit: Zhenan Bao labImbal

Updated on: June 03,2024

Stretchable probe measures brain chemicals central to Parkinson's, depression, and gut disease

by Stanford UniversityResearchers demonstrated the advantages of the flexible and elastic NeuroString technology by threading a probe through a segment of mouse colon. Credit: Zhenan Bao labImbal

Updated on:June 03,2024

Abnormalities in genes linked to IRSP in Alzheimer's disease

(HealthDay)—Individuals with Alzheimer's disease (AD) have abnormalities and reductions in gene expression in the parahippocampal gyri that map to genes associated with the insulin receptor signal

Updated on: April 18,2024

Abnormalities in genes linked to IRSP in Alzheimer's disease

(HealthDay)—Individuals with Alzheimer's disease (AD) have abnormalities and reductions in gene expression in the parahippocampal gyri that map to genes associated with the insulin receptor signal

Updated on:April 18,2024

Controversial Alzheimer's drug should not be approved out of desperation, warn Aussie experts

by Medical Journal of AustraliaCredit: Unsplash/CC0 Public DomainAducanumab, a controversial Alzheimer's disease medication with "questionable efficacy," is under review by the Therapeut

Updated on: April 25,2024

Controversial Alzheimer's drug should not be approved out of desperation, warn Aussie experts

by Medical Journal of AustraliaCredit: Unsplash/CC0 Public DomainAducanumab, a controversial Alzheimer's disease medication with "questionable efficacy," is under review by the Therapeut

Updated on:April 25,2024

Alzheimer's pathology, not cognitive decline, drives neuropsychiatric symptoms

by ElsevierFigure 1. Linear Mixed Effect Models displaying effects of pathology at baseline over time on the development of neuropsychiatric symptoms Plots of estimated marginal means and 95% CI

Updated on: April 07,2024

Alzheimer's pathology, not cognitive decline, drives neuropsychiatric symptoms

by ElsevierFigure 1. Linear Mixed Effect Models displaying effects of pathology at baseline over time on the development of neuropsychiatric symptoms Plots of estimated marginal means and 95% CI

Updated on:April 07,2024